Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
1(17%)
Results Posted
50%(1 trials)
Terminated
2(33%)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_2
3
50%
Ph phase_3
2
33%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(2)
Terminated(2)
Other(1)

Detailed Status

Completed2
Terminated2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (50.0%)
Phase 32 (33.3%)
N/A1 (16.7%)

Trials by Status

unknown117%
completed233%
recruiting117%
terminated233%

Recent Activity

1 active trials
Showing 5 of 6
recruitingnot_applicable

Evaluation of Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma

NCT01717924
terminatedphase_2

Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study

NCT03150628
unknownphase_3

Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis

NCT02912052
terminatedphase_3

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

NCT01189227
completedphase_2

Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma

NCT00168155
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01717924Not Applicable

Evaluation of Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma

Recruiting
NCT03150628Phase 2

Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study

Terminated
NCT02912052Phase 3

Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis

Unknown
NCT01189227Phase 3

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

Terminated
NCT00168155Phase 2

Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma

Completed
NCT00301548Phase 2

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6